How Raleigh's Sprout can benefit from FDA's approval of another female sexual disorder drug

The FDA ’s recent approval of a second drug to treat a female sexual disorder means competition for one Triangle drug-maker, but also the growth of an industry its CEO hopes will drive success for her firm.

Source: bizjournals.com Health Care News Headlines - June 25, 2019 Category: Health Management Authors: Seth Thomas Gulledge Source Type: news